<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font20 { font-size : 20; } .font22 { font-size : 22; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">CMV </span>
   <span class="font22">cytomegalovirus </span>
   <span class="font20">[]. </span>
   <span class="font16">viral </span>
   <span class="font16">infections </span>
   <span class="font16">infection </span>
   <span class="font15">target </span>
   <span class="font15">GBM </span>
   <span class="font14">HCMV </span>
   <span class="font14">brain </span>
   <span class="font14">patients </span>
   <span class="font14">{border-style </span>
   <span class="font14">px;} </span>
   <span class="font14">#ffffff;} </span>
   <span class="font14">cells </span>
   <span class="font14">human </span>
   <span class="font14">treatment </span>
   <span class="font13">DNA </span>
   <span class="font13">congenital </span>
   <span class="font13">latent </span>
   <span class="font13">therapy </span>
   <span class="font13">gene </span>
   <span class="font13">used </span>
   <span class="font13">Brain </span>
   <span class="font13">EGS </span>
   <span class="font13">Infect. </span>
   <span class="font13">vaccine </span>
   <span class="font12">CRISPR/Cas </span>
   <span class="font12">RNA </span>
   <span class="font12">cell </span>
   <span class="font12">clinical </span>
   <span class="font12">diseases </span>
   <span class="font12">tumor </span>
   <span class="font12">associated </span>
   <span class="font12">effective </span>
   <span class="font12">expression </span>
   <span class="font12">immune </span>
   <span class="font12">mental </span>
   <span class="font12">survival </span>
   <span class="font12">therapeutic </span>
   <span class="font12">[,]. </span>
   <span class="font12">early </span>
   <span class="font12">immunotherapy </span>
   <span class="font12">infections. </span>
   <span class="font12">online: </span>
   <span class="font12">results </span>
   <span class="font12">targeting </span>
   <span class="font12">transplant </span>
   <span class="font12">antiviral </span>
   <span class="font12">cause </span>
   <span class="font12">following </span>
   <span class="font12">genes </span>
   <span class="font12">primary </span>
   <span class="font12">replication </span>
   <span class="font12">specific </span>
   <span class="font12">treat </span>
   <span class="font12">using </span>
   <span class="font11">MCMV </span>
   <span class="font11">RNase </span>
   <span class="font11">[,] </span>
   <span class="font11">approaches </span>
   <span class="font11">drugs </span>
   <span class="font11">engineered </span>
   <span class="font11">genome </span>
   <span class="font11">glioblastoma </span>
   <span class="font11">murine </span>
   <span class="font11">organ </span>
   <span class="font11">prophylaxis </span>
   <span class="font11">protein </span>
   <span class="font11">px; </span>
   <span class="font11">vitro </span>
   <span class="font11">{font-family </span>
   <span class="font11">(e.g., </span>
   <span class="font11">However, </span>
   <span class="font11">active </span>
   <span class="font11">drug </span>
   <span class="font11">font-size </span>
   <span class="font11">growth </span>
   <span class="font11">host </span>
   <span class="font11">including </span>
   <span class="font11">infection: </span>
   <span class="font11">long-term </span>
   <span class="font11">phase </span>
   <span class="font11">recipients </span>
   <span class="font11">responses </span>
   <span class="font11">showed </span>
   <span class="font11">variants </span>
   <span class="font11">Clin. </span>
   <span class="font11">HHV-), </span>
   <span class="font11">anti-CMV </span>
   <span class="font11">approach </span>
   <span class="font11">brincidofovir </span>
   <span class="font11">demonstrated </span>
   <span class="font11">double; </span>
   <span class="font11">essential </span>
   <span class="font11">highly </span>
   <span class="font11">increased </span>
   <span class="font11">natural </span>
   <span class="font11">outcomes </span>
   <span class="font11">patient </span>
   <span class="font11">prevention </span>
   <span class="font11">proteins </span>
   <span class="font11">therapy, </span>
   <span class="font11">variant </span>
   <span class="font11">viruses </span>
   <span class="font11">Medication, </span>
   <span class="font11">TALENs </span>
   <span class="font11">activity </span>
   <span class="font11">application </span>
   <span class="font11">border-color </span>
   <span class="font11">border-width </span>
   <span class="font11">capsid </span>
   <span class="font11">complex </span>
   <span class="font11">developing </span>
   <span class="font11">development </span>
   <span class="font11">difficulty, </span>
   <span class="font11">disease </span>
   <span class="font11">efficacy </span>
   <span class="font11">hearing </span>
   <span class="font11">immediately </span>
   <span class="font11">latency </span>
   <span class="font11">lytic </span>
   <span class="font11">polymerase </span>
   <span class="font11">pp-specific </span>
   <span class="font11">retardation </span>
   <span class="font11">retardation, </span>
   <span class="font11">ribozyme </span>
   <span class="font11">shown </span>
   <span class="font11">solid; </span>
   <span class="font11">suggested </span>
   <span class="font11">{font-style </span>
   <span class="font11">{font-weight </span>
   <span class="font10">(CMV) </span>
   <span class="font10">Cancer </span>
   <span class="font10">Cytomegalovirus </span>
   <span class="font10">DCs </span>
   <span class="font10">Dis. </span>
   <span class="font10">Engl. </span>
   <span class="font10">February </span>
   <span class="font10">III </span>
   <span class="font10">Infection </span>
   <span class="font10">Maribavir </span>
   <span class="font10">Med. </span>
   <span class="font10">Med../NEJMoa </span>
   <span class="font10">National </span>
   <span class="font10">[,,,]. </span>
   <span class="font10">al.Letermovir </span>
   <span class="font10">allogeneic </span>
   <span class="font10">applied </span>
   <span class="font10">approved </span>
   <span class="font10">bold </span>
   <span class="font10">case </span>
   <span class="font10">courier; </span>
   <span class="font10">designed </span>
   <span class="font10">disease, </span>
   <span class="font10">effectively </span>
   <span class="font10">effects </span>
   <span class="font10">em; </span>
   <span class="font10">encode </span>
   <span class="font10">evidence </span>
   <span class="font10">external </span>
   <span class="font10">ganciclovir </span>
   <span class="font10">guide </span>
   <span class="font10">hematopoietic </span>
   <span class="font10">herpesvirus </span>
   <span class="font10">induce </span>
   <span class="font10">letermovir </span>
   <span class="font10">major </span>
   <span class="font10">management </span>
   <span class="font10">maternal </span>
   <span class="font10">novel </span>
   <span class="font10">patients. </span>
   <span class="font10">plasmids </span>
   <span class="font10">productive </span>
   <span class="font10">pt;} </span>
   <span class="font10">received </span>
   <span class="font10">reduced </span>
   <span class="font10">reduction </span>
   <span class="font10">remove </span>
   <span class="font10">risk </span>
   <span class="font10">role </span>
   <span class="font10">safety </span>
   <span class="font10">sequence </span>
   <span class="font10">significant </span>
   <span class="font10">significantly </span>
   <span class="font10">standard </span>
   <span class="font10">studies </span>
   <span class="font10">study </span>
   <span class="font10">survived </span>
   <span class="font10">symptomatic </span>
   <span class="font10">temozolomide </span>
   <span class="font10">toxicity </span>
   <span class="font10">trial </span>
   <span class="font10">usually </span>
   <span class="font10">virus </span>
  </p>
 </body>
</html>
